EGFR and non-small cell lung carcinoma: Furthermore, integrin β3 is specifically upregulated on the surface of NSCLC cells exposed to EGFR-TKI and is sufficient and necessary to reprogram NSCLC cells to a stemness phenotype with specific resistance to EGFR-TKI [14].